NOV 5, 2026 · JOURNAL ARTICLE
Advances in BCL6-targeted cancer therapy: From functional inhibition to PROTAC degradation
Oncology and Translational Medicine
B-cell lymphoma 6 (BCL6) is a transcriptional repressor essential for germinal center B-cell development, differentiation, and immune regulation. Aberrant overexpression or dysfunc